Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
J Biol Chem ; 291(12): 6218-31, 2016 Mar 18.
Article in English | MEDLINE | ID: mdl-26797118

ABSTRACT

Caveolin 1 (Cav-1) is an oligomeric protein that forms flask-shaped, lipid-rich pits, termed caveolae, on the plasma membrane. Cav-1 is targeted for lysosomal degradation in ubiquitination- and valosin-containing protein (VCP)-dependent manners. VCP, an ATPase associated with diverse cellular activities that remodels or segregates ubiquitinated protein complexes, has been proposed to disassemble Cav-1 oligomers on the endosomal membrane, facilitating the trafficking of Cav-1 to the lysosome. Genetic mutations in VCP compromise the lysosomal trafficking of Cav-1, leading to a disease called inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia (IBMPFD). Here we identified the Ankrd13 family of ubiquitin-interacting motif (UIM)-containing proteins as novel VCP-interacting molecules on the endosome. Ankrd13 proteins formed a ternary complex with VCP and Cav-1 and exhibited high binding affinity for ubiquitinated Cav-1 oligomers in an UIM-dependent manner. Mass spectrometric analyses revealed that Cav-1 undergoes Lys-63-linked polyubiquitination, which serves as a lysosomal trafficking signal, and that the UIMs of Ankrd13 proteins bind preferentially to this ubiquitin chain type. The overexpression of Ankrd13 caused enlarged hollow late endosomes, which was reminiscent of the phenotype of the VCP mutations in IBMPFD. Overexpression of Ankrd13 proteins also stabilized ubiquitinated Cav-1 oligomers on the limiting membrane of enlarged endosomes. The interaction with Ankrd13 was abrogated in IMBPFD-associated VCP mutants. Collectively, our results suggest that Ankrd13 proteins cooperate with VCP to regulate the lysosomal trafficking of ubiquitinated Cav-1.


Subject(s)
Adenosine Triphosphatases/physiology , Caveolin 1/metabolism , Cell Cycle Proteins/physiology , Lysosomes/metabolism , Membrane Proteins/physiology , Animals , COS Cells , Chlorocebus aethiops , Endosomes/metabolism , HeLa Cells , Humans , Protein Binding , Protein Stability , Protein Transport , Ubiquitin/metabolism , Ubiquitinated Proteins/metabolism , Ubiquitination , Valosin Containing Protein
2.
Nat Commun ; 9(1): 524, 2018 02 06.
Article in English | MEDLINE | ID: mdl-29410401

ABSTRACT

Protein ubiquitylation regulates diverse cellular processes via distinct ubiquitin chains that differ by linkage type and length. However, a comprehensive method for measuring these properties has not been developed. Here we describe a method for assessing the length of substrate-attached polyubiquitin chains, "ubiquitin chain protection from trypsinization (Ub-ProT)." Using Ub-ProT, we found that most ubiquitylated substrates in yeast-soluble lysate are attached to chains of up to seven ubiquitin molecules. Inactivation of the ubiquitin-selective chaperone Cdc48 caused a dramatic increase in chain lengths on substrate proteins, suggesting that Cdc48 complex terminates chain elongation by substrate extraction. In mammalian cells, we found that ligand-activated epidermal growth factor receptor (EGFR) is rapidly modified with K63-linked tetra- to hexa-ubiquitin chains following EGF treatment in human cells. Thus, the Ub-ProT method can contribute to our understanding of mechanisms regulating physiological ubiquitin chain lengths and composition.


Subject(s)
ErbB Receptors/metabolism , Polyubiquitin/analysis , Proteins/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Ubiquitination , Valosin Containing Protein/metabolism , Adaptor Proteins, Signal Transducing , Autophagy-Related Proteins , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Cycle Proteins/genetics , Cell Cycle Proteins/metabolism , Epidermal Growth Factor/pharmacology , HeLa Cells , Humans , Leupeptins/pharmacology , Polyubiquitin/chemistry , Polyubiquitin/metabolism , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Ubiquitin/chemistry , Ubiquitin/metabolism , Ubiquitinated Proteins/metabolism , Valosin Containing Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL